Products Categories
| CAS No.: | 201530-41-8 |
|---|---|
| Name: | Deferasirox |
| Article Data: | 36 |
| Molecular Structure: | |
|
|
|
| Formula: | C21H15N3O4 |
| Molecular Weight: | 373.368 |
| Synonyms: | 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoicacid;Benzoic acid,4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-;Exjade;ICL 670;ICL 670A; |
| EINECS: | 685-491-5 |
| Density: | 1.405 g/cm3 |
| Melting Point: | 260-2620C |
| Boiling Point: | 672.123 °C at 760 mmHg |
| Flash Point: | 360.287 °C |
| PSA: | 107.95000 |
| LogP: | 1.08550 |
- 483366-12-7(2S,4R)-1-Boc-2-cyano-4-hydroxypyrrolidine
- 361456-36-2METHYL (R)-(+)-ISOCYANATO-3-PHENYLPROPI&
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 47087-37-6Z-D-Glu-OMe
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 211914-50-0N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
- 240444-70-62,3,5,6-Tetrafluor-4-(methoxymethyl)benzyl-2,2-dimethyl-3-(prop-1-en-1-yl)cyclopropancarboxylat
- 10034-99-8Magnesium sulfate
- 1309-64-4Diantimony trioxide
- 7681-49-4Sodium fluoride
- 141-97-9Ethyl acetoacetate
- 13598-36-2Phosphonic acid
- 137071-32-0Pimecrolimus
- 77591-33-4Thymosin beta 4 acetate
- 24634-61-5Potassium sorbate
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
1. Introduction of Deferasirox
Deferasirox, with the IUPAC name of 4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid, is one kind of white or pale yellow powder which is a rationally-designed oral iron chelator. The product's categories are Chelating Agent (iron); Aromatics Compounds; Aromatics; Chelating Agents & Ligands; Heterocycles; Intermediates & Fine Chemicals; Pharmaceuticals.
2. Properties of Deferasirox
The other characteristics of Deferasirox can be summarized as: (1)ACD/LogP: 5.15; (2)# of Rule of 5 Violations: 1; (3)ACD/LogD (pH 5.5): 4; (4)ACD/LogD (pH 7.4): 3; (5)ACD/BCF (pH 5.5): 517; (6)ACD/BCF (pH 7.4): 21; (7)ACD/KOC (pH 5.5): 856; (8)ACD/KOC (pH 7.4): 35; (9)#H bond acceptors: 7; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 6 ; (12)Index of Refraction: 1.699; (13)Molar Refractivity: 102.604 cm3; (14)Molar Volume: 265.779 cm3; (15)Polarizability: 40.675×10-24 cm3; (16)Surface Tension: 60.846 dyne/cm; (17)Enthalpy of Vaporization: 103.723 kJ/mol; (18)Vapour Pressure: 0 mmHg at 25°C; (19)Rotatable Bond Count: 2; (20)Tautomer Count: 23; (21)Exact Mass: 373.106256; (22)MonoIsotopic Mass: 373.106256; (23)Topological Polar Surface Area: 98.7; (24)Heavy Atom Count: 28; (25)Complexity: 912.
3. Structure Descriptors of Deferasirox
You could convert the following datas into the molecular structure:
1). SMILES:OC(=O)c1ccc(cc1)n2nc(nc2c3ccccc3O)c4ccccc4O
2). InChI:InChI=1/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)
3). InChIKey:BOFQWVMAQOTZIW-UHFFFAOYAQ
4. Preparation of Deferasirox
Preparation of Deferasirox: It can be obtained by salicylic acid, salicylamide and 4-hydrazinobenzoic acid.
.gif)
5. Use of Deferasirox
Uses of Deferasirox: It is mainly used to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.